MicroRNAs as therapeutic targets in atherosclerosis (Q38281268)

1 September 2017

1 reference

title

MicroRNAs as therapeutic targets in atherosclerosis (English)

1 reference

1 September 2017

1 reference

1 reference

4

Alain Tedgui

1 reference

1 September 2017

2

Ziad Mallat

1 reference

1 September 2017

Xavier Loyer

1

0 references

Chantal M. Boulanger

object named as

Chantal M Boulanger

series ordinal

3

0 references

language of work or name

English

0 references

publication date

3 December 2014

1 reference

Expert Opinion on Therapeutic Targets

1 September 2017

published in

1 reference

1 September 2017

volume

19

1 reference

1 September 2017

issue

4

1 reference

1 September 2017

page(s)

489-496

1 reference

Discovery of the role of wall shear in atherosclerosis

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Cytokines in atherosclerosis: pathogenic and regulatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Origins and Mechanisms of miRNAs and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Biomechanical activation of vascular endothelium as a determinant of its functional phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

AMP-activated protein kinase regulates endothelial cell angiotensin-converting enzyme expression via p53 and the post-transcriptional regulation of microRNA-143/145.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNA-21 targets peroxisome proliferators-activated receptor-α in an autoregulatory loop to modulate flow-induced endothelial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: role of shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNA-145 Targeted Therapy Reduces Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/-mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Physiological and pathological roles for microRNAs in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Functional role of NF-κB in expression of human endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNA-24 regulates macrophage behavior and retards atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MiR-33 contributes to the regulation of cholesterol homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Microvesicles as cell-cell messengers in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Treatment of HCV infection by targeting microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.989835

10.1517/14728222.2014.989835

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference